Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.

Tolcher AW, Gordon M, Mahoney KM, Seto A, Zavodovskaya M, Hsueh CH, Zhai S, Tarnowski T, Jürgensmeier JM, Stinson S, Othman AA, Chen T, Strauss J

Open source

DOI: 10.1136/jitc-2022-005267
Published: 2023 Feb
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2022-005267,
  title = {Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.},
  author = {Tolcher AW and Gordon M and Mahoney KM and Seto A and Zavodovskaya M and Hsueh CH and Zhai S and Tarnowski T and Jürgensmeier JM and Stinson S and Othman AA and Chen T and Strauss J},
  year = {2023},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2022-005267},
  url = {https://doi.org/10.1136/jitc-2022-005267}
}

RIS

TY  - JOUR
TI  - Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.
AU  - Tolcher AW
AU  - Gordon M
AU  - Mahoney KM
AU  - Seto A
AU  - Zavodovskaya M
AU  - Hsueh CH
AU  - Zhai S
AU  - Tarnowski T
AU  - Jürgensmeier JM
AU  - Stinson S
AU  - Othman AA
AU  - Chen T
AU  - Strauss J
PY  - 2023
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2022-005267
UR  - https://doi.org/10.1136/jitc-2022-005267
ER  -

APA

AW, T., M, G., KM, M., A, S., M, Z., CH, H., S, Z., T, T., JM, J., S, S., AA, O., T, C., & J, S. (2023). Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2022-005267

Source records

pubmed · retrieved 2026-09-26T10:59:05.351Z